Endowment Managers' Compensation Reported

Harvard Management Company has issued its annual report on the compensation of its highest-earning investment professionals...

Harvard Management Company (HMC) has issued its annual report on the compensation of its most highly paid in-house investment professionals. The news, often the subject of close scrutiny, comes at a particularly sensitive time.

The managers' compensation is heavily performance-based: their base salaries are supplemented by substantial bonuses only if they exceed market rates of return in the asset classes for which they are responsible--and, further, sustain that return over time (if performance subsequently lags, bonuses earned but not yet paid out can be "clawed back"). During fiscal year 2008, which ended last June 30, HMC achieved an 8.6 percent return on endowment assets--much better than the 13.1 percent decline in the Standard & Poor's index of large U.S. stocks and even ahead of the 7.1 percent return on the broadest bond-market proxy. The aggregate return for the fiscal year exceeded market returns of 6.9 percent on HMC's benchmarks for its portfolio overall, yielding an extra "value-added" margin of investment return, worth $600 million to the endowment. During the stellar fiscal 2007 year, HMC's aggregate return was 23 percent: 5.8 percentage points better than market benchmarks, representing extra endowment returns of $1.7 billion.

Those halcyon days--which in fact drive much of this year's bonus awards--are of course overshadowed in memory by the recent sharp decline in the value of Harvard's endowment, and those of all known peer institutions, reflecting the rout in financial markets worldwide since last summer. (Whatever the returns for the current fiscal year turn out to be, they may, of course, be relatively better or worse than the performance of the relevant market benchmarks for HMC's asset classes; that, in turn, will figure into compensation awards for future years.)

According to the news release, these were the five highest-paid employees (figures include salaries, bonuses, and benefits):

Stephen Blyth, $6.4 million, Managing Director--International Fixed Income

Marc Seidner, $6.3 million, Managing Director--Domestic Fixed Income

Stanley Zuzic, $4.9 million, Senior Vice President--Domestic Equities

Steven Alperin, $4.4 million. Managing Director--Emerging Market Equities

Andrew Wiltshire,$3.9 million, Managing Director--Natural Resources

In addition, Mohamed El-Erian, former president and CEO, was paid $921,000. He announced his intention to resign and to return to his previous employer in California, in September 2007, and departed that December. 

For past coverage of HMC compensation, including some explanation of the performance-related bonus system, see also here and here.

 

You might also like

Harvard Graduate Student Union Authorizes Another Strike

The University warns this walkout may not be protected by labor law, an assertion the union disputes.

FAS Readies for Administrative Transition

Faculty leaders say layoffs will yield $20 million in annual savings.

When Government Funding Dropped, Harvard Found Partners

The University is expanding industry ties and investing its own funds to support research, but neither will replace lost federal dollars.

Most popular

Harvard Stabilizes Finances With Strong Endowment Returns, Philanthropy

Small operating surplus is dwarfed by reduced federal research support and endowment tax liabilities.

Kari Nadeau

Multi-allergy immunotherapy pioneer Kari Nadeau returns to Harvard

“Find Your Way to Heal This World”

A virtual Convocation for the College class of 2024

Explore More From Current Issue

St. Peter's Basilica at sunset, illuminated by purple and orange sky reflections in the river.

For advocacy and benevolence, three late alumni are reportedly in line for the Catholic Church’s highest honor.

Delicate green cocoa pods and small white flowers on a tree branch, surrounded by soft greenery.

Harvard researchers investigate climate’s impact on cocoa crops, innovations in nasal vaccines, and links between pain and skull marrow.

Illuminated hanging sculptures resembling organic forms, casting warm light in a dim space.

Artists Enzo Camacho and Ami Lien turn a colonial symbol from Cambodia inside out.